{"slug":"slu-pp-332","seoKey":"slupp332","displayName":"SLU-PP-332","codes":["SLU-PP-332","SR9861"],"synonyms":["ERR agonist SLU-PP-332","estrogen-related receptor pan-agonist","4-hydroxy-N'-(naphthalen-2-ylmethylene)benzohydrazide","SLU PP 332","SLU-PP-915 (the successor compound is a DIFFERENT substance)"],"legalClass":"research_chemical","identifiers":{"cas":"303760-60-3","pubchemCid":5338394,"inchikey":"RNZIMBFHRXYRLL-XDHOZWIPSA-N","chemblId":"CHEMBL4208749","wikidataQid":"Q122902396","formula":"C18H14N2O2","molecularWeight":290.32},"approvals":[{"market":"US","status":"not_approved","note":"Not approved, not part of any approved medicinal product and no pharmacopoeial monograph. On none of the compounding lists and never nominated for one; a full-text search of the stored list pages on 2026-09-07 returned no entry. Not being listed here means the substance never entered the procedure at all, not that it was assessed and cleared. Sold formally for research use only, which is a seller's disclaimer and not a statement about identity, purity or sterility.","source":"https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-used-compounding-under-section-503a-fdc-act"},{"market":"EU","status":"not_approved","note":"No marketing authorisation and no monograph in the European Pharmacopoeia. Not authorised as a food ingredient either; as a novel food it would require an authorisation and does not have one.","source":"https://www.ema.europa.eu/en/medicines?search_api_fulltext=SLU-PP-332"},{"market":"DE","status":"not_approved","note":"No marketing authorisation; a substance with a medicinal purpose may not be placed on the market without one. Named neither in narcotics legislation nor in the new psychoactive substances act nor by name in the annex to the anti-doping act.","source":"https://www.gesetze-im-internet.de/amg_1976/__21.html"},{"market":"UK","status":"not_approved","note":"No marketing authorisation and no substance-specific regulatory measure found. Not verified against a primary regulator document on 2026-09-07.","source":"https://products.mhra.gov.uk/search/?search=SLU-PP-332"},{"market":"AU","status":"not_approved","note":"No marketing authorisation and not named in the Poisons Standard; the full text was searched on 2026-09-07 under the code name, the chemical class and two structural terms with no hit. The absence of an entry is not a clearance, and it marks a status difference rather than a safety statement.","source":"https://www.legislation.gov.au/F2026L00633/asmade"},{"market":"CA","status":"not_approved","note":"No marketing authorisation and no substance-specific regulatory measure found. Not verified against a primary regulator document on 2026-09-07.","source":"https://health-products.canada.ca/api/drug/activeingredient/?ingredientname=SLU-PP-332"},{"market":"CH","status":"not_approved","note":"No marketing authorisation found on 2026-09-07.","source":"https://www.swissmedicinfo.ch/"}],"devStage":"preclinical","strongestEvidence":"animal","wada":{"status":"prohibited","section":"S0","listYear":2026,"source":"https://www.wada-ama.org/en/prohibited-list"},"trials":[],"sameAs":["https://www.wikidata.org/wiki/Q122902396","https://pubchem.ncbi.nlm.nih.gov/compound/5338394","https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4208749/"],"lastVerified":"2026-09-07","version":"1.0","published":true,"locale":"en","title":"SLU-PP-332: what the studies show, status and safety","summary":"SLU-PP-332 is not a peptide. It is a small synthetic molecule that switches on the estrogen-related receptors, which control how cells burn fuel, and it sits in this register because it is sold as a peptide. Not a single study in people exists. In mice it raised endurance and cut fat gain, but only when injected, because its developers state it is not absorbed when swallowed.","updated":"2026-09-07","url":"https://mypep.app/peptides/slu-pp-332"}